| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.3 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.054 | 0.3 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.3 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |